G. Bullock

发表

Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells

John Calvin Reed, K. Bhalla, A. M. Ibrado, 1997, Leukemia.

Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.

John Calvin Reed, K. Bhalla, Y. Huang, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells.

K. Bhalla, A. M. Ibrado, J. Lutzky, 1992, Gynecologic oncology.

Characterization of a human myeloid leukemia cell line highly resistant to taxol.

K. Bhalla, A. M. Ibrado, Y. Huang, 1994, Leukemia.

Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.

K. Bhalla, T. Miyashita, Y. Huang, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Combined antileukemic activity of pIXY 321 and Ara-C against human acute myeloid leukemia cells.

K. Bhalla, A. M. Ibrado, Y. Huang, 1994, Leukemia & lymphoma.

High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells.

K. Bhalla, A. M. Ibrado, S. Grant, 1993, Blood.

Improved Antileukemic Activity of the Combination of Ara-C with GM-CSF and IL-3 Fusion Protein (PIXY321)

K. Bhalla, A. M. Ibrado, S. Ray, 1996 .

Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.

K. Bhalla, A. M. Ibrado, G. Núñez, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Impact of p16 expression on surgical management of malignant melanoma and pancreatic carcinoma.

P. Baron, G. Bullock, J. L. Green, 1999, American journal of surgery.

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells

K. Bhalla, A. M. Ibrado, J. Lutzky, 1993 .

1-β-d-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation

K. Bhalla, A. M. Ibrado, S. Ray, 1994, Cancer Chemotherapy and Pharmacology.

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.

K. Bhalla, A. M. Ibrado, Y. Huang, 1993, Experimental hematology.

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal and leukemic bone marrow progenitor cells.

K. Bhalla, A. M. Ibrado, J. Lutzky, 1992, Leukemia.

Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.

J. Reed, K. Bhalla, A. M. Ibrado, 1996, Leukemia.

High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.

J. Reed, K. Bhalla, T. Miyashita, 1994, Leukemia.